Skip to main content

Table 3 Comparison of MR imaging Characteristics between Type 1 AIP Patients with and without PaT

From: Pancreatic tumor in type 1 autoimmune pancreatitis: a diagnostic challenge

 

AIP (n = 19)

AIP + PaC (n = 1)

P Value

Pancreatic parenchyma

 Enlargement pattern

  

0.250

  Diffuse

15 (79%)

0 (0%)

 

  Focal

4 (21%)

1 (100%)

 

 Presence of atrophy

2 (11%)

1 (100%)

0.150

 Signal intensity on T1WI

  Hypointense

16 (84%)

1 (100%)

0.911

  Isointense

2 (11%)

0 (0%)

 

  Hyperintense

1 (5%)

0 (0%)

 

  Presence of heterogeneity

5 (26%)

0 (0%)

1.000

 Signal intensity on T2WI

  Hypointense

0 (0%)

0 (0%)

0.452

  Isointense

7 (37%)

0 (0%)

 

  Hyperintense

12 (63%)

1 (100%)

 

  Presence of heterogeneity

6 (31%)

1 (100%)

0.300

 Signal intensity on pancreatic phase

  Hypointense

13 (69%)

1 (100%)

0.502

  Isointense

6 (31%)

0 (0%)

 

  Hyperintense

0 (0%)

0 (0%)

 

  Presence of heterogeneity

12 (63%)

1 (100%)

1.000

 Signal intensity on portal venous phase

  Hypointense

1 (5%)

0 (0%)

0.798

  Isointense

5 (26%)

0 (100%)

 

  Hyperintense

13 (69%)

1 (0%)

 

  Presence of heterogeneity

6 (31%)

1 (100%)

0.350

 Signal intensity on delayed venous phase

  Hypointense

3 (16%)

0 (0%)

0.753

  Isointense

12 (63%)

1 (100%)

 

  Hyperintense

4 (21%)

0 (0%)

 

  Presence of heterogeneity

5 (26%)

1 (100%)

0.300

 Presence of rim enhancement

0 (0%)

1 (100%)

0.050

Main pancreatic duct

 Presence of dilatation

3 (16%)

0 (0%)

1.000

 Presence of cutoff

6 (31%)

1 (100%)

0.350

Peripancreatic structures

 Presence of halo sign

1 (5%)

0 (0%)

1.000

 Presence of stranding

0 (0%)

0 (0%)

1.000

 Presence of ascites

0 (0%)

0 (0%)

1.000

 Presence of vessel stricture

13 (69%)

1 (100%)

1.000

  1. Abbreviations: AIP autoimmune pancreatitis, PaT pancreatic tumor
  2. Data are expressed as absolute values (percentages)